"The mechanistic basis of cancer immunotherapy" | 30 October 2024
During this Grand Rounds, experts discuss "The mechanistic basis of cancer immunotherapy" Presenter: Ira Mellman, PhD, Vice President of Cancer Immunology at Genentech Learn more: https://medicine.stanford.edu/
